BDO has appointed Graeme Hurst as a life sciences & pharma partner in the transaction services team to lead on due diligence. He has extensive experience of delivering due diligence services to both private equity and corporate clients across the sector in the UK and internationally, having previously led the regional pharma and healthcare transaction services team at PwC. Hurst will be working with high growth, innovative, mid-market businesses within the life sciences and pharma sector and will be advising on the regional management of national private equity clients. He will be based in Birmingham and London.